ATE311453T1 - Grf-analoge mit erhöhter biologischer potenz - Google Patents

Grf-analoge mit erhöhter biologischer potenz

Info

Publication number
ATE311453T1
ATE311453T1 AT99941349T AT99941349T ATE311453T1 AT E311453 T1 ATE311453 T1 AT E311453T1 AT 99941349 T AT99941349 T AT 99941349T AT 99941349 T AT99941349 T AT 99941349T AT E311453 T1 ATE311453 T1 AT E311453T1
Authority
AT
Austria
Prior art keywords
grf
increased biological
biological potency
potency
present
Prior art date
Application number
AT99941349T
Other languages
English (en)
Inventor
Denis Gravel
Abdelkrim Habi
Paul Brazeau
Original Assignee
Theratechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/148,982 external-priority patent/US6020311A/en
Application filed by Theratechnologies Inc filed Critical Theratechnologies Inc
Application granted granted Critical
Publication of ATE311453T1 publication Critical patent/ATE311453T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99941349T 1998-09-08 1999-09-07 Grf-analoge mit erhöhter biologischer potenz ATE311453T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/148,982 US6020311A (en) 1995-05-26 1998-09-08 GRF analogs with increased biological potency
US09/389,486 US6458764B1 (en) 1995-05-26 1999-09-03 GRF analogs with increased biological potency
PCT/CA1999/000816 WO2000014236A2 (en) 1998-09-08 1999-09-07 Grf analogs with increased biological potency

Publications (1)

Publication Number Publication Date
ATE311453T1 true ATE311453T1 (de) 2005-12-15

Family

ID=26846360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99941349T ATE311453T1 (de) 1998-09-08 1999-09-07 Grf-analoge mit erhöhter biologischer potenz

Country Status (12)

Country Link
US (2) US6458764B1 (de)
EP (1) EP1109909B1 (de)
JP (1) JP2002524472A (de)
KR (1) KR100474868B1 (de)
AT (1) ATE311453T1 (de)
AU (1) AU755852B2 (de)
BR (1) BR9913515A (de)
CA (1) CA2342070A1 (de)
DE (2) DE1109909T1 (de)
ES (1) ES2164626T1 (de)
MX (1) MXPA01002468A (de)
WO (1) WO2000014236A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458764B1 (en) * 1995-05-26 2002-10-01 Theratechnologies Inc. GRF analogs with increased biological potency
WO2002010195A2 (en) * 2000-08-02 2002-02-07 Theratechnologies Inc. Modified peptides with increased potency
WO2004027064A2 (en) * 2002-09-18 2004-04-01 Centre Hospitalier De L'universite De Montreal (Chum) Ghrh analogues
KR20050074492A (ko) * 2002-10-22 2005-07-18 와라타 파마수티컬즈, 인크. 당뇨병의 치료
AU2003229222B2 (en) 2003-05-29 2009-11-12 Theratechnologies Inc. GRF analog compositions and their use
DE602004018339D1 (de) * 2003-09-02 2009-01-22 Yissum Res Dev Co Oxazaborolidine als bakterielle effektoren
AU2004281084B2 (en) * 2003-10-20 2010-08-12 Theratechnologies Inc. Use of growth hormone releasing factor analogs in treating patients suffering from wasting
EP1812048A4 (de) * 2004-10-20 2012-01-18 Theratechnologies Inc Gh-sekretagoga und ihre verwendung
JP2008534639A (ja) * 2005-04-08 2008-08-28 ロンザ ア−ゲ− Ｐｅｇ樹脂上におけるアルファ−ヘリックスのペプチド合成
EP2952522B1 (de) 2007-01-31 2019-10-30 Dana-Farber Cancer Institute, Inc. Stabilisierte P53-Peptide und deren Verwendungen
AU2008232709C1 (en) 2007-03-28 2015-01-15 President And Fellows Of Harvard College Stitched polypeptides
WO2011153491A2 (en) 2010-06-03 2011-12-08 University Of Miami Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
KR20170058446A (ko) 2010-08-13 2017-05-26 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
AR088392A1 (es) 2011-10-18 2014-05-28 Aileron Therapeutics Inc Macrociclos peptidomimeticos
US9079974B2 (en) 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CA2862038C (en) 2012-02-15 2021-05-25 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
BR112015009470A2 (pt) 2012-11-01 2019-12-17 Aileron Therapeutics Inc aminoácidos dissubstituídos e seus métodos de preparação e uso
WO2014100816A2 (en) 2012-12-21 2014-06-26 University Of Miami Ghrh agonists for islet cell transplantation and function and the treatment of diabetes
WO2014100809A2 (en) 2012-12-21 2014-06-26 University Of Miami Ghrh agonists for the treatment of ischemic disorders
WO2016049359A1 (en) 2014-09-24 2016-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US10253067B2 (en) 2015-03-20 2019-04-09 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2023014978A2 (en) * 2021-08-06 2023-02-09 Rebalance Health, Inc. Growth hormone-releasing hormone peptides and formulations thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914189A (en) * 1987-02-05 1990-04-03 The Adminstrators Of The Tulane Educational Fund Synthetic GHRH analogs
US5112808A (en) * 1987-05-11 1992-05-12 American Cyanamid Company Alkylated hormone-releasing peptides and method of treatig mammals therewith
EP0527914A4 (en) * 1990-05-04 1993-08-11 The Administrators Of The Tulane University Educational Fund Novel synthetic grf analogs
JP3576170B2 (ja) * 1995-05-26 2004-10-13 セラテクノロジーズ・インコーポレーテッド 生物学的活性が増加したキメラ脂肪体プロｇｒｆ類似体
US6020311A (en) * 1995-05-26 2000-02-01 Theratechnologies, Inc. GRF analogs with increased biological potency
US6458764B1 (en) * 1995-05-26 2002-10-01 Theratechnologies Inc. GRF analogs with increased biological potency

Also Published As

Publication number Publication date
JP2002524472A (ja) 2002-08-06
CA2342070A1 (en) 2000-03-16
EP1109909B1 (de) 2005-11-30
DE69928677D1 (de) 2006-01-05
WO2000014236A2 (en) 2000-03-16
WO2000014236A3 (en) 2000-06-02
ES2164626T1 (es) 2002-03-01
BR9913515A (pt) 2001-06-05
DE1109909T1 (de) 2002-05-23
AU5500799A (en) 2000-03-27
MXPA01002468A (es) 2002-04-24
EP1109909A2 (de) 2001-06-27
AU755852B2 (en) 2002-12-19
US6458764B1 (en) 2002-10-01
KR20010086368A (ko) 2001-09-10
US20040171534A1 (en) 2004-09-02
KR100474868B1 (ko) 2005-03-08

Similar Documents

Publication Publication Date Title
DK0828758T3 (da) Kimæriske fedtlegeme-pro-GRF-analoger med forøget biologisk potensering
ATE311453T1 (de) Grf-analoge mit erhöhter biologischer potenz
ATE494902T1 (de) Ein huhn gnrh-ii analog zur verwendung in der reduktion des tumorzellwachstums
UA19303A (uk) Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу
HU9400495D0 (en) Peptides having growth hormone releasing activity
IL129126A0 (en) Monocyclic l-nucleosides analogs and uses thereof
AT389445B (de) Orale zubereitung, insbesondere zur bekaempfung von mundgeruch
ES2187575T3 (es) Hexapeptidos ciclicos dotados de actividad antibiotica.
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
IT1206341B (it) Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
DE68909409D1 (de) Heilmitteldosierung zur verabreichung an fische.
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
GR3023038T3 (en) Use of coconut precursor fatty acid as insect-repellent.
DK0540676T3 (da) Peptidforbindelser med væksthormonfrigivende aktivitet
ES8700054A1 (es) Procedimiento de obtencion de germicidas a base de acidos clorhidrico y fosforico.
GR3029319T3 (en) Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity
IL85029A (en) Microcrystalline cis diammineplatinum(ii)complex of 1,1-cyclobutanedicarboxylic acid,its preparation and cytostatic pharmaceutical compositions containing it
RU93016862A (ru) Водно-глицериновый комплекс (2,3-диоксипропил)-орто-титана-хлорид
IT1283134B1 (it) Derivati sintetici e semisintetici di somatostatine utili nella stimolazione della crescita corporea, in particolare in
RU97120474A (ru) Биологически активная кормовая добавка для сельскохозяйственных птиц
UA19786A (uk) Засіб для обробки бульб кортоплі перед посадкою
钱敏儒 The Fountain of Life
ATE39697T1 (de) Erythromycin-a-salz mit mucosecretolytischer und fluidisierender aktivitaet, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
ECSP972038A (es) Fomento del crecimiento de pollos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties